IL6 and non-small cell lung carcinoma: Our results showing that both IL-6 and cachexia severity were independent predictive factors of PFS and OS in patients with NSCLC under ICI support the hypothesis that the negative associations between cachexia and ICI efficacy can mainly be attributed to chronic inflammation, as we reported in a recent review [24].